Currently Enrolling Outpatient
Yellow Fever Vaccine Study (CIR 333)


The purpose of this study is to demonstrate that a new (investigational) yellow fever vaccine is as safe and protective against yellow fever infection as the currently licensed yellow fever vaccine.  The study (is):

  • enrolling 18-60 year olds
  • includes 1 vaccination day visit
  • includes 9-10 follow up visits over 5 years
  • Pays $870-950 depending on visits completed

Complete the CIR Contact Form

Screening Dates

Screening appointments will be scheduled individually.

Screening Location

CIR at Johns Hopkins Bayview Medical Campus
301 Building 4th Floor
301 Mason Lord Drive
Baltimore, MD 21224

Study Period

5 year follow up period (one visit year 2, one visit year 3, one visit year 4 and one visit year 5)



Translate »